title: Interregional Coevolution Analysis Revealing Functional and Structural Interrelatedness between Different Genomic Regions in Human Mastadenovirus D.
abstract: Human mastadenovirus D (HAdV-D) is exceptionally rich in type among the seven human adenovirus species. This feature is attributed to frequent intertypic recombination events that have reshuffled orthologous genomic regions between different HAdV-D types. However, this trend appears to be paradoxical, as it has been demonstrated that the replacement of some of the interacting proteins for a specific function with other orthologues causes malfunction, indicating that intertypic recombination events may be deleterious. In order to understand why the paradoxical trend has been possible in HAdV-D evolution, we conducted an interregional coevolution analysis between different genomic regions of 45 different HAdV-D types and found that ca. 70% of the genome has coevolved, even though these are fragmented into several pieces via short intertypic recombination hot spot regions. Since it is statistically and biologically unlikely that all of the coevolving fragments have synchronously recombined between different genomes, it is probable that these regions have stayed in their original genomes during evolution as a platform for frequent intertypic recombination events in limited regions. It is also unlikely that the same genomic regions have remained almost untouched during frequent recombination events, independently, in all different types, by chance. In addition, the coevolving regions contain the coding regions of physically interacting proteins for important functions. Therefore, the coevolution of these regions should be attributed at least in part to natural selection due to common biological constraints operating on all types, including protein-protein interactions for essential functions. Our results predict additional unknown protein interactions.
  
  
  OBJECTIVE
  Human mastadenovirus D, an exceptionally type-rich human adenovirus species and causative agent of different diseases in a wide variety of tissues, including that of ocular region and digestive tract, as well as an opportunistic infection in immunocompromised patients, is known to have highly diverged through frequent intertypic recombination events; however, it has also been demonstrated that the replacement of a component protein of a multiprotein system with a homologous protein causes malfunction. The present study solved this apparent paradox by looking at which genomic parts have coevolved using a newly developed method. The results revealed that intertypic recombination events have occurred in limited genomic regions and been avoided in the genomic regions encoding proteins that physically interact for a given function. This approach detects purifying selection against recombination events causing the replacement of partial components of multiprotein systems and therefore predicts physical and functional interactions between different proteins and/or genomic elements.
authors.affiliation: Graduate School of Information Science and Technology, Hokkaido University, Sapporo, Japan.
authors.forename: Gabriel
authors.initials: G
authors.lastname: Gonzalez
authors.affiliation: Graduate School of Information Science and Technology, Hokkaido University, Sapporo, Japan.
authors.forename: Kanako O
authors.initials: KO
authors.lastname: Koyanagi
authors.affiliation: Department of Ophthalmology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
authors.forename: Koki
authors.initials: K
authors.lastname: Aoki
authors.affiliation: Graduate School of Information Science and Technology, Hokkaido University, Sapporo, Japan watanabe@ist.hokudai.ac.jp.
authors.forename: Hidemi
authors.initials: H
authors.lastname: Watanabe
mesh_terms: D019143:Evolution, Molecular; D014644:Genetic Variation; D016679:Genome, Viral; D006801:Humans; D017921:Mastadenovirus / Q000145:classification* / Q000235:genetics*; D011485:Protein Binding; D011995:Recombination, Genetic; D012641:Selection, Genetic; D014764:Viral Proteins / Q000235:genetics / Q000378:metabolism
chemical_list: D014764:Viral Proteins
references.citation: J Virol. 2006 Dec;80(23):11827-32
references.pmid: 16971423
references.citation: J Virol. 1989 Dec;63(12):5133-41
references.pmid: 2585600
references.citation: Nat Rev Mol Cell Biol. 2007 Dec;8(12):995-1005
references.pmid: 18037900
references.citation: J Virol. 2001 Jan;75(2):699-709
references.pmid: 11134283
references.citation: J Biol Chem. 2000 May 19;275(20):14969-78
references.pmid: 10747932
references.citation: J Gen Virol. 2011 Dec;92(Pt 12):2770-5
references.pmid: 21880842
references.citation: J Gen Virol. 2003 Nov;84(Pt 11):2895-908
references.pmid: 14573794
references.citation: Cancer Res. 1967 Feb;27(2):209-20
references.pmid: 6018555
references.citation: J Gen Virol. 1995 Aug;76 ( Pt 8):1959-69
references.pmid: 7636476
references.citation: Int J Biol Sci. 2010;6(7):730-55
references.pmid: 21152115
references.citation: Mol Biol Evol. 1987 Jul;4(4):406-25
references.pmid: 3447015
references.citation: J Mol Evol. 1992 Feb;34(2):126-9
references.pmid: 1556748
references.citation: J Virol. 1994 Jun;68(6):3917-24
references.pmid: 8189528
references.citation: J Virol. 1998 Mar;72(3):2388-97
references.pmid: 9499099
references.citation: Proc Int Conf Intell Syst Mol Biol. 1998;6:175-82
references.pmid: 9783223
references.citation: J Biol Chem. 2001 Feb 2;276(5):3270-8
references.pmid: 11050095
references.citation: J Virol. 2009 Mar;83(6):2697-707
references.pmid: 19116260
references.citation: J Gen Virol. 2009 Jan;90(Pt 1):1-20
references.pmid: 19088268
references.citation: Oncogene. 2005 Nov 21;24(52):7673-85
references.pmid: 16299528
references.citation: Science. 2010 Aug 27;329(5995):1038-43
references.pmid: 20798312
references.citation: Mol Biol Evol. 1993 May;10(3):512-26
references.pmid: 8336541
references.citation: J Clin Microbiol. 2011 Oct;49(10):3482-90
references.pmid: 21849694
references.citation: J Virol. 2002 Sep;76(18):9194-206
references.pmid: 12186903
references.citation: Syst Biol. 2001 Nov-Dec;50(6):945-69
references.pmid: 12116642
references.citation: J Virol. 2011 Jun;85(11):5703-4
references.pmid: 21450837
references.citation: PLoS Pathog. 2007 Nov;3(11):e181
references.pmid: 18052529
references.citation: Nucleic Acids Res. 2002 Jul 15;30(14):3059-66
references.pmid: 12136088
references.citation: J Virol. 2008 May;82(9):4585-94
references.pmid: 18287244
references.citation: Infect Genet Evol. 2011 Aug;11(6):1208-17
references.pmid: 21570490
references.citation: J Virol. 2012 Jan;86(1):635-6
references.pmid: 22158846
references.citation: AIDS Res Hum Retroviruses. 2005 Jan;21(1):98-102
references.pmid: 15665649
references.citation: Genetics. 2007 Jun;176(2):1035-47
references.pmid: 17409078
references.citation: Genome Announc. 2013 Jan;1(1):null
references.pmid: 23405334
references.citation: Nucleic Acids Res. 2012 Jul;40(13):5795-818
references.pmid: 22467216
references.citation: Bioinformatics. 2000 Jul;16(7):573-82
references.pmid: 11038328
references.citation: Virology. 2011 Aug 15;417(1):9-17
references.pmid: 21605885
references.citation: J Virol. 2002 Aug;76(16):8200-7
references.pmid: 12134025
references.citation: J Virol. 2001 Oct;75(19):8875-87
references.pmid: 11533151
references.citation: J Virol. 1997 Sep;71(9):6381-9
references.pmid: 9261355
references.citation: J Virol. 2011 Aug;85(15):7849-55
references.pmid: 21632753
references.citation: Curr Top Microbiol Immunol. 2003;272:187-211
references.pmid: 12747551
references.citation: J Virol. 2000 Dec;74(24):11681-9
references.pmid: 11090167
references.citation: J Gen Virol. 2011 Jun;92(Pt 6):1251-9
references.pmid: 21402595
references.citation: Bioinformatics. 2000 Jun;16(6):562-3
references.pmid: 10980155
references.citation: J Gen Virol. 1997 Sep;78 ( Pt 9):2131-8
references.pmid: 9291998
references.citation: J Virol. 2009 May;83(9):4000-12
references.pmid: 19211739
references.citation: J Virol. 1997 Feb;71(2):1115-23
references.pmid: 8995632
references.citation: J Virol. 2008 May;82(10):5089-92
references.pmid: 18337584
references.citation: Oncogene. 2004 Sep 30;23(45):7458-68
references.pmid: 15334069
references.citation: Virology. 1999 Dec 20;265(2):218-25
references.pmid: 10600594
references.citation: J Biol Chem. 2012 Sep 7;287(37):31582-95
references.pmid: 22791715
references.citation: J Clin Invest. 2006 Nov;116(11):2901-13
references.pmid: 17024246
references.citation: Gene. 2014 Aug 15;547(1):10-7
references.pmid: 24726548
references.citation: Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13757-62
references.pmid: 11717435